Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056715 · ClinicalTrials.gov registry record
Extended ECG Monitoring in HCM Patients
A clinical trial, sponsored by iRhythm Technologies.
- Completed
- Registry status
- 250
- Enrollment target
NCT04056715: Completed study, sponsored by iRhythm Technologies.
NCT04056715 is a clinical trial that has completed, run by iRhythm Technologies. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04056715 has completed, sponsored by iRhythm Technologies.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to determine, among a large cohort of 300 consecutive patients with hypertrophic cardiomyopathy, if extended ambulatory monitoring using the iRhythm Technologies, Inc. Zio XT device results in identifying a greater burden of nonsustained ventricular tachyarrhythmia (nsVT) compared to current ACCF/AHA guideline recommended 48-hour monitoring.
Primary Outcome
Compare the number of nsVT runs detected between the first 48 hours vs 2 weeks of ambulatory cardiac monitoring.
Interventions
- DEVICE Zio XT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-01-14 |
| Est. Completion | 2022-04-18 |
What the finished NCT04056715 record still lists
NCT04056715 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Zio XT is the first listed.
NCT04056715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04056715 about?
NCT04056715 is a clinical study titled "Extended ECG Monitoring in HCM Patients". The purpose of this study is to determine, among a large cohort of 300 consecutive patients with hypertrophic cardiomyopathy, if extended ambulatory monitoring using the iRhythm Technologies, Inc. Zio XT device results in identifying a greater burden of nonsustained ventricular tachyarrhythmia (nsVT...
What is the current status of trial NCT04056715?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2020-01-14. Estimated completion is 2022-04-18.
What interventions are being tested in trial NCT04056715?
The interventions under investigation include: Zio XT (DEVICE).
Who is sponsoring clinical trial NCT04056715?
This trial is sponsored by iRhythm Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI